Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care

References

• Janghorbani M Van Dam RM Willett WC Hu FB Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture Am J Epidemiol 2007 166 495 505 17575306
   PubMed Web of Science ®Google Scholar
• Janghorbani M Feskanich D Willett WC Hu F Prospective study of diabetes and risk of hip fracture: the Nurses’ Health Study Diabetes Care 2006 29 1573 1578 16801581
   PubMed Web of Science ®Google Scholar
• Bonds DE Larson JC Schwartz AV Risk of fracture in women with type 2 diabetes: the women’s health initiative observational study J Clin Endocrinol Metab 2006 91 3404 3410 16804043
   PubMed Web of Science ®Google Scholar
• Melton LJ3rd Leibson CL Achenbach SJ Therneau TM Khosla S Fracture risk in type 2 diabetes: update of a population-based study J Bone Miner Res 2008 23 1334 1342 18348689
   PubMed Web of Science ®Google Scholar
• Grey A Diabetes medications and bone Curr Osteoporos Rep 2015 13 35 40 25433437
   PubMed Web of Science ®Google Scholar
• Monami M Cresci B Colombini A Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case–control study Diabetes Care 2008 31 199 203 18024851
   PubMed Web of Science ®Google Scholar
• Ahmed LA Joakimsen RM Berntsen GK Fonnebo V Schirmer H Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study Osteoporos Int 2006 17 495 500 16283065
   PubMed Web of Science ®Google Scholar
• Napoli N Strotmeyer ES Ensrud KE Fracture risk in diabetic elderly men: the MrOS study Diabetologia 2014 57 2057 2065 24908567
   PubMed Web of Science ®Google Scholar
• Johnston SS Conner C Aagren M Ruiz K Bouchard J Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes Diabetes Obes Metab 2012 14 634 643 22335246
   PubMed Web of Science ®Google Scholar
• Suissa S Garbe E Primer: administrative health databases in observational studies of drug effects – advantages and disadvantages Nat Clin Pract Rheumatol 2007 3 725 732 18037932
   PubMedGoogle Scholar
• Vestergaard P Rejnmark L Mosekilde L Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk Diabetologia 2005 48 1292 1299 15909154
   PubMed Web of Science ®Google Scholar
• Rathmann W Kostev K Gruenberger JB Dworak M Bader G Giani G Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulpho-nylureas: a primary care database analysis Diabetes Obes Metab 2013 15 55 61 22862879
   PubMed Web of Science ®Google Scholar
• Kowall B Rathmann W Kostev K Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis Diabetes Care 2015 38 59 65 25336750
   PubMed Web of Science ®Google Scholar
• Becher H Kostev K Schröder-Bernhardi D Validity and representativeness of the Disease Analyzer patient database for use in pharmacoepidemiological and pharmacoeconomic studies Int J Clin Pharm Therap 2009 47 617 626
   PubMed Web of Science ®Google Scholar
• Quan H Sundararajan V Halfon P Coding algorithms for defining co-morbidities in ICD-9-CM and ICD-10 administrative data Med Care 2005 43 1130 1139 16224307
   PubMed Web of Science ®Google Scholar
• Swart E Good practice of secondary data analysis, first revision Gesundheitswesen 2008 70 54 60 18273764
   PubMed Web of Science ®Google Scholar
• Motheral B Brooks J Clark MA A checklist for retrospective database studies – Report from the ISPOR task force on retrospective databases Value Health 2003 6 90 97 12641858
   PubMed Web of Science ®Google Scholar
• Oei L Rivadeneira F Zillikens MC Oei EH Diabetes, diabetic complications, and fracture risk Curr Osteoporos Rep 2015 13 106 115 25648962
   PubMed Web of Science ®Google Scholar
• Ehnert S Freude T Ihle C Factors circulating in the blood of type 2 diabetes mellitus patients affect osteoblast maturation – Description of a novel in vitro model Exp Cell Res 2015 332 247 258 25557875
   PubMed Web of Science ®Google Scholar
• Ivers RQ Cumming RG Mitchell P Peduto AJ Blue Mountains Eye Study. Diabetes and risk of fracture: the Blue Mountains Eye Study Diabetes Care 2001 24 1198 1203 11423502
   PubMed Web of Science ®Google Scholar
• Holman RR Thorne KI Farmer AJ Addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes N Engl J Med 2007 357 1716 1730 17890232
   PubMed Web of Science ®Google Scholar
• Janka HU Plewe G Riddle MC Kliebe-Frisch C Schweitzer MA Yki-Järvinen H Comparison of basal insulin added to oral agents versus twice-daily premixed insulin therapy for type 2 diabetes Diabetes Care 2005 28 254 259 15677775
   PubMed Web of Science ®Google Scholar
• Bretzel RG Nuber U Landgraf W Owens DR Bradley C Linn T Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomized controlled trial Lancet 2008 371 1073 1084 18374840
   PubMed Web of Science ®Google Scholar
• Mullins P Sharplin P Yki-Järvinen H Riddle MC Haring HU Negative binominal meta-regression analysis of combined glycosylated hemoglo-bin and hypoglycaemia outcomes across eleven phase III an IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus Clin Ther 2007 29 1607 1619 17919543
   PubMed Web of Science ®Google Scholar
• Rosenstock J Fonseca V Schinzel S Dain MP Mullins P Riddle M Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: evidence from a long-term controlled trial J Diabetes Complications 2014 28 742 749 24856612
   PubMed Web of Science ®Google Scholar
• Malabu UH Vangaveti VN Kennedy RL Disease burden evaluation of fall-related events in the elderly due to hypoglycemia and other diabetic complications: a clinical review Clin Epidemiol 2014 6 287 294 25152631
   PubMed Web of Science ®Google Scholar
• Kennedy RL Henry J Chapman AJ Nayar R Grant P Morris AD Accidents in patients with insulin-treated diabetes: increased risk of low-impact falls but not motor vehicle crashes – a prospective register-based study J Trauma 2002 52 660 666 11956379
   PubMedGoogle Scholar
• Lapane KL Yang S Brown MJ Jawahar R Pagliasotti C Rajpathak S Sulfonylureas and risk of falls and fractures: a systematic review Drugs Aging 2013 30 527 547 23609875
   PubMed Web of Science ®Google Scholar
• Wallace C Reiber GE LeMaster J Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer Diabetes Care 2002 25 1983 1986 12401743
   PubMed Web of Science ®Google Scholar
• Gregg EW Beckles GL Williamson DF Diabetes and physical disability among older U.S. adults Diabetes Care 2000 23 1272 1277 10977018
   PubMed Web of Science ®Google Scholar
• Kroger H Tuppurainen M Honkanen R Alhava E Saarikoski S Bone mineral density and risk factors for osteoporosis–a population-based study of 1600 perimenopausal women Calcif Tissue Int 1994 55 1 7 7922782
   PubMed Web of Science ®Google Scholar
• Jørgensen TS Hansen AH Sahlberg M Falls and comorbidity: the pathway to fractures Scand J Public Health 2014 42 287 294 24434943
   PubMed Web of Science ®Google Scholar
• Hyde Z Mylankal KJ Hankey GJ Flicker L Norman PE Peripheral arterial disease increases the risk of subsequent hip fracture in older men: the health in men study Osteoporos Int 2013 24 1683 1688 23160917
   PubMed Web of Science ®Google Scholar